1. Home
  2. ORGO vs GBAB Comparison

ORGO vs GBAB Comparison

Compare ORGO & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • GBAB
  • Stock Information
  • Founded
  • ORGO 1985
  • GBAB 2010
  • Country
  • ORGO United States
  • GBAB United States
  • Employees
  • ORGO N/A
  • GBAB N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • GBAB Investment Managers
  • Sector
  • ORGO Health Care
  • GBAB Finance
  • Exchange
  • ORGO Nasdaq
  • GBAB Nasdaq
  • Market Cap
  • ORGO 376.8M
  • GBAB 398.8M
  • IPO Year
  • ORGO N/A
  • GBAB N/A
  • Fundamental
  • Price
  • ORGO $2.98
  • GBAB $14.91
  • Analyst Decision
  • ORGO Buy
  • GBAB
  • Analyst Count
  • ORGO 2
  • GBAB 0
  • Target Price
  • ORGO $5.50
  • GBAB N/A
  • AVG Volume (30 Days)
  • ORGO 1.6M
  • GBAB 69.4K
  • Earning Date
  • ORGO 05-08-2025
  • GBAB 01-01-0001
  • Dividend Yield
  • ORGO N/A
  • GBAB 9.18%
  • EPS Growth
  • ORGO N/A
  • GBAB N/A
  • EPS
  • ORGO N/A
  • GBAB N/A
  • Revenue
  • ORGO $458,760,000.00
  • GBAB N/A
  • Revenue This Year
  • ORGO $2.73
  • GBAB N/A
  • Revenue Next Year
  • ORGO $12.28
  • GBAB N/A
  • P/E Ratio
  • ORGO N/A
  • GBAB N/A
  • Revenue Growth
  • ORGO 5.35
  • GBAB N/A
  • 52 Week Low
  • ORGO $2.28
  • GBAB $14.22
  • 52 Week High
  • ORGO $6.71
  • GBAB $17.44
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 35.44
  • GBAB 44.28
  • Support Level
  • ORGO $2.61
  • GBAB $14.72
  • Resistance Level
  • ORGO $3.28
  • GBAB $14.99
  • Average True Range (ATR)
  • ORGO 0.14
  • GBAB 0.16
  • MACD
  • ORGO 0.01
  • GBAB 0.01
  • Stochastic Oscillator
  • ORGO 34.59
  • GBAB 60.00

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest

Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.

Share on Social Networks: